Predictions
Tilray Inc
Start price
Target price
Perf. (%)
€4.14
15.11.22
15.11.22
€6.00
15.11.23
15.11.23
-28.55%
15.01.23
15.01.23
Could be worthwhile Investment >10% per year
Moderna Inc.
Start price
Target price
Perf. (%)
€174.50
15.11.22
15.11.22
€200.00
15.11.23
15.11.23
-59.80%
16.11.23
16.11.23
Capable Management
Medium risks for its business
Small cyclical dependencies
Could be very worthwhile Investment >20% year
AMTD IDEA Group ADR
Start price
Target price
Perf. (%)
€1.99
14.11.22
14.11.22
-
14.11.23
14.11.23
-29.65%
18.02.23
18.02.23
Could be very worthwhile Investment >20% year
LiveRamp Holdings, Inc.
Start price
Target price
Perf. (%)
€20.95
14.11.22
14.11.22
-
14.11.23
14.11.23
14.08%
26.01.23
26.01.23
Moderna Inc.
Start price
Target price
Perf. (%)
€164.38
14.11.22
14.11.22
€175.00
14.11.23
14.11.23
9.00%
16.11.22
16.11.22
Normal challenges to pay loans and raise capital
Innovative
Some uniques
Differentiated customer and product portfolio
AMTD IDEA Group ADR
Start price
Target price
Perf. (%)
€1.99
14.11.22
14.11.22
€2.00
14.11.23
14.11.23
-29.65%
26.11.22
26.11.22
Could be worthwhile Investment >10% per year
Very capable Management
Few uniques
Hamburger Hafen und Logistik AG
Start price
Target price
Perf. (%)
€12.70
13.11.22
13.11.22
-
13.11.23
13.11.23
34.96%
13.09.23
13.09.23
NIBE Industrier AB
Start price
Target price
Perf. (%)
€9.23
13.11.22
13.11.22
€14.00
13.11.23
13.11.23
-38.04%
13.11.23
13.11.23
Raiffeisen Bank International AG
Start price
Target price
Perf. (%)
€15.14
13.11.22
13.11.22
-
13.11.23
13.11.23
11.96%
06.01.23
06.01.23
Could be worthwhile Investment >10% per year
High dividend yield expected
High risks for its business
Tilray Inc
Start price
Target price
Perf. (%)
€4.06
12.11.22
12.11.22
€5.00
12.11.23
12.11.23
5.43%
03.12.22
03.12.22
Innovative
Growths faster than the competition
Well known brand
Very small cyclical dependencies
Sixt SE ST
Start price
Target price
Perf. (%)
€99.50
12.11.22
12.11.22
€100.00
12.11.23
12.11.23
5.33%
18.01.23
18.01.23
EBIT growth >5% per year expected
Top Rating
Very valuable balance sheet
Normal challenges to pay loans and raise capital